Search Clinical Trials
606,324 trials
ID
Status
Phase
Title
Sponsor
NCT07868562
Gastroesophageal Reflux and Respiratory Function in Patients Undergoing AbdominoplastyUniversidade Federal de PernambucoNot Yet Recruiting
NCT07868562Not Yet Recruiting
—
Gastroesophageal Reflux and Respiratory Function in Patients Undergoing Abdomino...Universidade Federal de P...
NCT07868302
Caffeine-Induced Thermogenesis Assessed by Infrared ThermographyIstanbul Health and Technology UniversityCompletedNot Applicable
NCT07868302Completed
Not Applicable
Caffeine-Induced Thermogenesis Assessed by Infrared ThermographyIstanbul Health and Techn...
NCT07869615
Comparison of DOACs and LMWH for Thromboprophylaxis After Total Knee ArthroplastyMilitary Hospital of TunisRecruitingNot Applicable
NCT07869615Recruiting
Not Applicable
Comparison of DOACs and LMWH for Thromboprophylaxis After Total Knee Arthroplast...Military Hospital of Tuni...
NCT07868744
Clinical Assessment of UV Photofunctionalization on Stability and Osseointegration of Early Loaded ImplantsFuture University in EgyptActive Not RecruitingNot Applicable
NCT07868744Active Not Recruiting
Not Applicable
Clinical Assessment of UV Photofunctionalization on Stability and Osseointegrati...Future University in Egyp...
NCT07869641
Improved Breast Enlargement Using the Subject's Own Fat Tissue4TissueRecruitingNot Applicable
NCT07869641Recruiting
Not Applicable
Improved Breast Enlargement Using the Subject's Own Fat Tissue4Tissue
NCT07869264
An Observational Study of LEQEMBI in Routine Clinical Practice in TaiwanEisai Taiwan Inc.Not Yet Recruiting
NCT07869264Not Yet Recruiting
—
An Observational Study of LEQEMBI in Routine Clinical Practice in TaiwanEisai Taiwan Inc.
NCT07867405
The Effect of Tail Fat Application on Joint Pain, Joint Stiffness, and Daily Living Activities in Patients With GonarthrosisInonu UniversityRecruitingNot Applicable
NCT07867405Recruiting
Not Applicable
The Effect of Tail Fat Application on Joint Pain, Joint Stiffness, and Daily Liv...Inonu University
NCT07868172
GST101 in Participants With RAS-Mutant Advanced Solid TumorsGenuine Seed Therapeutics (Zhuhai) Co., Ltd.Not Yet RecruitingPhase 1
NCT07868172Not Yet Recruiting
Phase 1
GST101 in Participants With RAS-Mutant Advanced Solid TumorsGenuine Seed Therapeutics...
NCT07868653
Exercise Intervention to Support Recovery After Allogeneic Stem Cell Transplantation in Adults With Myeloid Blood DisordersUniversität Duisburg-EssenNot Yet RecruitingNot Applicable
NCT07868653Not Yet Recruiting
Not Applicable
Exercise Intervention to Support Recovery After Allogeneic Stem Cell Transplanta...Universität Duisburg-Esse...
NCT07868432
Glycemic Impact of NNS Via the Gut MicrobiomeTufts Medical CenterEnrolling By InvitationNot Applicable
NCT07868432Enrolling By Invitation
Not Applicable
Glycemic Impact of NNS Via the Gut MicrobiomeTufts Medical Center
NCT07869693
Pre-induction Norepinephrine in Septic Patients Undergoing SurgeryAssiut UniversityNot Yet RecruitingNot Applicable
NCT07869693Not Yet Recruiting
Not Applicable
Pre-induction Norepinephrine in Septic Patients Undergoing SurgeryAssiut University
NCT07869420
Evaluating Feasibility and Acceptability of Pain EducationNational Cancer Institute (NCI)CompletedNot Applicable
NCT07869420Completed
Not Applicable
Evaluating Feasibility and Acceptability of Pain EducationNational Cancer Institute...
NCT07869563
Ultrasound-assisted Nasal Bone Fracture ReductionSecond Affiliated Hospital, Zhejiang University, School of MedicineRecruitingNot Applicable
NCT07869563Recruiting
Not Applicable
Ultrasound-assisted Nasal Bone Fracture ReductionSecond Affiliated Hospita...
NCT07867938
A Clinical Trial of Tulisokibart (MK-7240) in Participants With Pulmonary Sarcoidosis (MK-7240-016)Merck Sharp & Dohme LLCNot Yet RecruitingPhase 2
NCT07867938Not Yet Recruiting
Phase 2
A Clinical Trial of Tulisokibart (MK-7240) in Participants With Pulmonary Sarcoi...Merck Sharp & Dohme LLC
NCT07868497
Comparison of Suboccipital Release and Muscle Energy Technique in Subjects With Mechanical Neck Pain and Forward Head PostureKing Edward Medical UniversityNot Yet RecruitingNot Applicable
NCT07868497Not Yet Recruiting
Not Applicable
Comparison of Suboccipital Release and Muscle Energy Technique in Subjects With...King Edward Medical Unive...
NCT07869628
A Multicenter, Randomized, Controlled Phase III Clinical Trial on Adjuvant Intensified Therapy for Patients With Residual Disease After Neoadjuvant Treatment for Triple-negative Breast CancerShandong Cancer Hospital and InstituteNot Yet RecruitingPhase 3
NCT07869628Not Yet Recruiting
Phase 3
A Multicenter, Randomized, Controlled Phase III Clinical Trial on Adjuvant Inten...Shandong Cancer Hospital...
NCT07869602
Efficacy and Safety of the Angionix Balloon in Patients With Coronary Artery Disease Undergoing PTCANOBAMEDI CO., LTD.Not Yet Recruiting
NCT07869602Not Yet Recruiting
—
Efficacy and Safety of the Angionix Balloon in Patients With Coronary Artery Dis...NOBAMEDI CO., LTD.
NCT07867015
Transcutaneous Auricular Vagus Nerve Stimulation to Improve Upper Extremity Recovery After Traumatic Brain InjuryCraig HospitalNot Yet RecruitingNot Applicable
NCT07867015Not Yet Recruiting
Not Applicable
Transcutaneous Auricular Vagus Nerve Stimulation to Improve Upper Extremity Reco...Craig Hospital
NCT07868939
Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2)Viking Therapeutics, Inc.Not Yet RecruitingPhase 3
NCT07868939Not Yet Recruiting
Phase 3
Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase...Viking Therapeutics, Inc.
NCT07868796
Natural History and Genotype-Phenotype Correlations in Mitochondrial LeukoencephalopathiesFondazione I.R.C.C.S. Istituto Neurologico Carlo BestaRecruiting
NCT07868796Recruiting
—
Natural History and Genotype-Phenotype Correlations in Mitochondrial Leukoenceph...Fondazione I.R.C.C.S. Ist...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting5 (25%)
Completed2 (10%)
Active, not recruiting1 (5%)
Enrolling by invitation1 (5%)
not_applicable12 (60%)
Not Specified4 (20%)
Phase 32 (10%)
Phase 11 (5%)
Phase 21 (5%)